Document Detail


Intracoronary thrombolysis with urokinase in acute myocardial infarction. Effects on reperfusion and left ventricular wall motion.
MedLine Citation:
PMID:  6759286     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Intracoronary Urokinase administration was attempted in 20 patients (mean age 56 years) during the early phase of an acute evolving myocardial infarction. One patient died before urokinase infusion could be started. Out of the remaining nineteen patients, eighteen had total occlusion of a coronary vessel; one patient, in cardiogenic shock, failed to show occluding thrombi of the vessel related to the ECG site of infarction, and died during the procedure. Urokinase was administered at a rate of 4000 IU/min in 7 consecutive patients (Group I), 6000 IU/min in 5 patients (Group II), and 10000 IU/min in 6 patients (Group III). Recanalization of the occluded vessel was obtained in 16 patients (88%). The reperfusion time was 52 +/- 33 min. No significant variation in reperfusion time was noted in the three groups of patients treated. The time elapsed between the onset of symptoms and the successful recanalization was in our patients 4.3 +/- 1.8 hours. Ventricular arrhythmias, which required treatment, appeared after reperfusion in five patients. No serious hemorrhagic complications were noted. In fourteen patients ventriculography was performed before and immediately after thrombolysis: 15 patients had the study repeated 12 days after the procedure. Patency persisted in 13 patients and successful thrombolysis was associated with significant improvement in left ventricular ejection fraction and segmental wall motion. Our data demonstrate that different doses of Urokinase can be safely and successfully used to produce intracoronary thrombolysis in the majority of patients with acute myocardial infarction.
Authors:
C Cernigliaro; M Sansa; A Campi; A Sante Bongo; P Rossi
Related Documents :
2973486 - Insights derived from the thrombolysis and angioplasty in myocardial infarction (tami) ...
8232456 - Triggering of acute myocardial infarction by heavy physical exertion. protection agains...
8141716 - Early thrombolytic treatment in acute coronary thrombosis.
9706826 - Prevention of congestive heart failure by early, prehospital thrombolysis in acute myoc...
214526 - Correlations of tc-99m pyrophosphate myocardial scintigraphy and the results of coronar...
18036586 - Differential effects of the sodium calcium exchange inhibitor, kb-r7943, on ischemia an...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Giornale italiano di cardiologia     Volume:  12     ISSN:  0046-5968     ISO Abbreviation:  G Ital Cardiol     Publication Date:  1982  
Date Detail:
Created Date:  1983-03-24     Completed Date:  1983-03-24     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  1270331     Medline TA:  G Ital Cardiol     Country:  ITALY    
Other Details:
Languages:  eng     Pagination:  365-73     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Coronary Disease / drug therapy
Coronary Vessels
Endopeptidases / administration & dosage*
Female
Humans
Male
Middle Aged
Myocardial Infarction / drug therapy*
Urokinase-Type Plasminogen Activator / administration & dosage*,  therapeutic use
Chemical
Reg. No./Substance:
EC 3.4.-/Endopeptidases; EC 3.4.21.73/Urokinase-Type Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of oral calcium-antagonists in spontaneous angina. Verapamil and nifedipine in a double-blin...
Next Document:  Successful regional immunotherapy with cell-wall skeletons of BCG and Nocardia rubra against autocht...